financetom
Business
financetom
/
Business
/
T. Rowe Price Group Launches Tax-Free Bond Exchange-Traded Fund
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
T. Rowe Price Group Launches Tax-Free Bond Exchange-Traded Fund
Jul 10, 2024 7:49 AM

10:42 AM EDT, 07/10/2024 (MT Newswires) -- T. Rowe Price Group ( TROW ) said it added a federally tax-free fixed income exchange-traded fund to its active ETF roster.

T. Rowe Price Intermediate Municipal Income ETF (TAXE) started trading Wednesday on the Nasdaq, according to the company.

The ETF strategy will focus on investment-grade intermediate-term municipal bonds with an average maturity between four to 12 years, T. Rowe said. The ETF has a net expense ratio of 0.24%.

Price: 115.44, Change: +0.97, Percent Change: +0.85

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Hyatt To Acquire Standard International And Its Iconic Hotel Brands
BRIEF-Hyatt To Acquire Standard International And Its Iconic Hotel Brands
Aug 20, 2024
Aug 20 (Reuters) - Hyatt Hotels Corp ( H ): * HYATT TO ACQUIRE STANDARD INTERNATIONAL AND ITS ICONIC HOTEL BRANDS, THE STANDARD AND BUNKHOUSE HOTELS, EXPANDING ITS LEADING POSITION IN LIFESTYLE HOSPITALITY Source text for Eikon: Further company coverage: ...
Aadi Bioscience Shares Fall as Tumor Treatment Trial Halted; Job Cuts Planned
Aadi Bioscience Shares Fall as Tumor Treatment Trial Halted; Job Cuts Planned
Aug 20, 2024
05:59 PM EDT, 08/20/2024 (MT Newswires) -- Aadi Bioscience ( AADI ) shares fell 27% in after-hours trading Tuesday after the company said its Precision1 trial of nab-sirolimus in cancer patients is unlikely to meet the efficacy threshold for regulatory approval. The company said it decided to halt the tumor-agnostic therapy trial and will instead focus on marketing Fyarro, its...
Golub Capital Bdc Insider Bought Shares Worth $587,600, According to a Recent SEC Filing
Golub Capital Bdc Insider Bought Shares Worth $587,600, According to a Recent SEC Filing
Aug 20, 2024
05:24 PM EDT, 08/20/2024 (MT Newswires) -- David Golub, Director, Chief Executive Officer, on August 16, 2024, executed a purchase for 40,000 shares in Golub Capital Bdc ( GBDC ) for $587,600. Following the Form 4 filing with the SEC, Golub has control over a total of 7,408,213 shares of the company, with 125,388 shares held directly and 7,282,825 controlled...
BRIEF-Agilysys Announces Strategic Acquisition Of Book4time
BRIEF-Agilysys Announces Strategic Acquisition Of Book4time
Aug 20, 2024
Aug 20 (Reuters) - Agilysys Inc ( AGYS ): * AGILYSYS ANNOUNCES STRATEGIC ACQUISITION OF BOOK4TIME, A SPA MANAGEMENT SAAS SOLUTION LEADER * AGILYSYS INC ( AGYS ): ALL-CASH TRANSACTION CLOSED FOR APPROXIMATELY $150 MILLION Source text for Eikon: Further company coverage: ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved